Overview
What is Mucolipidosis Type Iv Foundation Inc?
Mucolipidosis Type Iv Foundation Inc, situated in Atlanta, Georgia, is a small nonprofit organization with a mission to combat Mucolipidosis Type IV, a rare genetic disorder. They raise funds from individuals and companies to support medical research grants, hoping to unravel the causes and symptoms of this disease, ultimately leading to a potential cure. Based at 1440 Spring Street, they contribute to groundbreaking studies at Massachusetts General Hospital. The foundation's work extends beyond monetary contributions, as it aims to foster collaborative research efforts towards finding a cure for Mucolipidosis Type IV.
Official website here: www.ml4.org
Is Mucolipidosis Type Iv Foundation Inc legitimate?
Mucolipidosis Type Iv Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Mucolipidosis Type Iv Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $160,608
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.ml4.org
What is the mission statement of Mucolipidosis Type Iv Foundation Inc?
The Mucolipidosis Type Iv Foundation Inc's mission is centered around raising funds from individuals and companies to support medical research. The primary goal is to provide research grants to scientists studying the cause and symptoms of Mucolipidosis Type Iv, with the ultimate aim of discovering a cure for this disease. The foundation's activities are focused on funding research, with the hope that advancements will lead to improved understanding and eventual eradication of Mucolipidosis Type Iv.
Official website here: www.ml4.org
Who is the CEO of Mucolipidosis Type Iv Foundation Inc?
Rebecca Oberman is the Executive Director of Mucolipidosis Type Iv Foundation Inc.
Official website here: www.ml4.org
What is the revenue of Mucolipidosis Type Iv Foundation Inc?
Mucolipidosis Type Iv Foundation Inc's revenue in 2022 was $860,271.
Official website here: www.ml4.org
Who are the executives of Mucolipidosis Type Iv Foundation Inc and what are their salaries?
The average compensation at Mucolipidosis Type Iv Foundation Inc during 2022 was $80,304. There are 2 employees and 6 volunteers at Mucolipidosis Type Iv Foundation Inc.
Here are 7 key members and their salaries:
- Rebecca Oberman (Executive Director)
- Randy Gold (President Treasurer) [Trustee/Director]
- Caroline Gold (Secretary) [Trustee/Director]
- Paula Kutner (Board Member) [Trustee/Director]
- Michael Friedman (Board Member) [Trustee/Director]
- Debra Goldschmidt (Board Member) [Trustee/Director]
- Nathaniel Fernhoff (Board Member) [Trustee/Director]
Official website here: www.ml4.org
Where can I find the form 990 for Mucolipidosis Type Iv Foundation Inc?
The Mucolipidosis Type Iv Foundation Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.ml4.org
Learn more at the official website: www.ml4.org
Mission Statement of Mucolipidosis Type Iv Foundation Inc
The Mucolipidosis Type Iv Foundation Inc is dedicated to funding medical research grants aimed at uncovering the causes and alleviating the symptoms of Mucolipidosis Type Iv, with the ultimate goal of discovering a cure for this disease. The foundation, with a mission to raise contributions from individuals and companies, channels these funds to researchers studying Mucolipidosis Type Iv, hoping to make significant strides in finding a solution to this debilitating condition. By supporting medical research, the Mucolipidosis Type Iv Foundation Inc is actively contributing to the global effort to combat this disease and improve the lives of those affected by it.
Impact
This information is meant to be a general summary of Mucolipidosis Type Iv Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Mucolipidosis Type IV Foundation Inc's impact lies in its dedicated efforts to raise contributions from individuals and companies to fund medical research grants aimed at finding a cure for Mucolipidosis Type IV. By providing funding for research initiatives focused on understanding the cause and symptoms of this disease, the foundation is actively contributing to the pursuit of a cure for Mucolipidosis Type IV. This targeted approach plays a crucial role in advancing medical knowledge and potentially improving the lives of individuals affected by this condition.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
1982
Phone
(877) 654-5459
Principal Officer
Rebecca Oberman
Main Address
1440 SPRING STREET, ATLANTA, GA, 30309
Website
www.ml4.org
NTEE Category
Code: G20 - Disease
If you are a representative of Mucolipidosis Type Iv Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.